Diabetes is one of the largest epidemics in human history. Based on the International Diabetes Foundation (IDF Alas 10th Edition), there are 537 million adults living with diabetes (10%) with a prediction to rise to 783 million by 2045. Diabetes is responsible for 6.7 million deaths in 2021 (1 every 5 seconds). It caused at least $966 billion in health expenditure — a 316% increase over the last 15 years. However, technology-enabled solutions to address diabetes are being created.
Join this webinar to learn about technology-enabled solutions to address the diabetes epidemic. Discussions regarding innovation that support early detection and prevention for the impaired glucose tolerance (IGT) population and the undiagnosed. Discover innovative solutions such as sensors, delivery and drugs for type 1 diabetes (T1D) and type 2 diabetes (T2D) adults. Also, learn about the impact of new innovative paradigms on diagnosis, treatments and prevention of diabetes and its impact on people with diabetes (PWD).
The featured speakers will review the current state and future state of technologies that will enable better outcomes for diabetes.
Dr. Aiman Abdel-Malek, Digital Connected Healthcare Investor, Board Member & Advisor; Executive Chairman, Thirdwayv Inc. Board of Advisors
Dr. Aiman Abdel-Malek brings over 25 years of experience as a senior executive leading healthcare business team to develop innovative customer-centric business solutions. Dr. Abdel-Malek is currently the Executive Chairman, Advisory Board of Thirdwayv Inc., the leading company in secure connected healthcare solutions headquartered in Irvine California.
Previously, he served as a Public Company Officer and Executive Vice President at Insulet Corporation (NASDAQ: Podd) until his retirement in April 2019. Prior to assuming this role, he was Insulet’s Senior Vice President, Advanced Technology and Engineering. Under his leadership, Insulet launched the first FDA cleared smartphone controlled tubeless Insulin patch pump in the world — the Omnipod DASH platform-based connected diabetes management products.
Aiman holds a PhD in Biomedical Engineering from the University of Southern California. He is an expert Consultant to various financial investment firms in digital diabetes management market. Aiman serves as a Board Advisor to Biolinq, Inc. (San Diego, CA), CuePath Innovation (British Columbia, Canada) and Cigniti Corporation (symbol: Cigniti.BO). He is the Chairperson of the Industry Advisory Board of the University of Pennsylvania PRECISE Center for Safe AI. He has over 30 patents and publications and is a frequent keynote speaker at various digital healthcare, secure IoT and mobile digital healthcare forums.
Lutz Heinemann, Professor, Profil Institut für Stoffwechselforschung GmbH
Lutz Heinemann studied process engineering at the University of Applied Sciences in Düsseldorf, Germany, receiving his degree in 1976 and went on to study biology at the University of Düsseldorf, qualifying as a Biologist in 1982. He worked for three years as an Assistant Professor in the Neurophysiology Department at Düsseldorf University.
He went on to work with Professor M. Berger at the Clinic for Nutrition and Metabolism from 1985 to 1999. In 1999, he founded the Profil Institut für Stoffwechselforschung in Neuss, Germany. He was the CEO until 2009.
He is a member of national and international diabetes associations. He also sits on the scientific advisory boards of various pharmaceutical and diagnostics companies. Since 2011, he has been the Managing Editor of the Journal of Diabetes Science and Technology. His scientific research is focused on insulin pharmacology and diabetes technology. Between 2010 and 2015, he acted as coordinator for the EU-funded project AP@home.
David Bottcher-Baek, Head of Connected Health, Phillips-Medisize
David Bottcher-Baek serves as the Head of Connected Health at Phillips-Medisize. Within this pivotal role, he plays a key role in a global team dedicated to crafting cutting-edge solutions for connected drug delivery and advancing the landscape of connected health.
He has over 15 years of experience spanning diverse cross-functional engineering disciplines and has consistently held leadership positions, steering product development teams and identifying strategic business opportunities. Over the past six years, he has honed a specialized focus on the evolution of connected devices, mobile applications and the development of robust ecosystems for seamless data management.
David holds a distinguished master’s degree in Mechatronic Engineering and a PhD in ultrasonics from the prestigious Technical University of Denmark. Furthermore, David has augmented this foundation with a mini-MBA, showcasing a well-rounded approach to both technical and business realms.
Who Should Attend?
This webinar will appeal to professionals in the following fields:
- Product management/product development/NPI
- Category/commodity management
- Sourcing/procurement/supply chain
- Pharma c-suite
- Medtech c-suite
- Healthcare insurance
- Sick found
What You Will Learn
Attendees will gain insights into:
- Technology-enabled solutions to address early detection and prevention for the (IGT) population and the undiagnosed
- Innovative solutions for Type 1 and Type 2 people with diabetes
- The impact of new innovative paradigms on diagnosis, treatments and prevention of diabetes
- The cybersecurity impact of increasingly connected diabetes technology solutions
- The Food and Drug Administration (FDA) and medical device reporting (MDR) impact on bringing innovative solutions to market
Product realization has never been more complex. Phillips-Medisize supports today’s specialization, regulation, and digitization for fast, efficient product launch on a global scale. For over 60 years Phillips-Medisize has helped companies develop and manufacture innovative products that help people live healthier and more productive lives.